Free Trial

Helius Medical Technologies (HSDT) Competitors

Helius Medical Technologies logo
$4.42 +0.07 (+1.61%)
Closing price 04:00 PM Eastern
Extended Trading
$4.43 +0.01 (+0.23%)
As of 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HSDT vs. AEMD, LYRA, BLAC, CHEK, LUCY, NUWE, AMIX, GCTK, HSCS, and QNRX

Should you be buying Helius Medical Technologies stock or one of its competitors? The main competitors of Helius Medical Technologies include Aethlon Medical (AEMD), Lyra Therapeutics (LYRA), Bellevue Life Sciences Acquisition (BLAC), Check-Cap (CHEK), Innovative Eyewear (LUCY), Nuwellis (NUWE), Autonomix Medical (AMIX), GlucoTrack (GCTK), Heart Test Laboratories (HSCS), and Quoin Pharmaceuticals (QNRX). These companies are all part of the "medical equipment" industry.

Helius Medical Technologies vs.

Aethlon Medical (NASDAQ:AEMD) and Helius Medical Technologies (NASDAQ:HSDT) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, community ranking, analyst recommendations, dividends, media sentiment, institutional ownership and profitability.

Aethlon Medical has a net margin of 0.00% compared to Helius Medical Technologies' net margin of -1,764.74%. Aethlon Medical's return on equity of -153.96% beat Helius Medical Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Aethlon MedicalN/A -153.96% -109.13%
Helius Medical Technologies -1,764.74%-244.82%-127.10%

Aethlon Medical currently has a consensus target price of $7.00, suggesting a potential upside of 1,654.39%. Given Aethlon Medical's stronger consensus rating and higher probable upside, equities analysts clearly believe Aethlon Medical is more favorable than Helius Medical Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aethlon Medical
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Helius Medical Technologies
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

2.0% of Aethlon Medical shares are held by institutional investors. Comparatively, 18.6% of Helius Medical Technologies shares are held by institutional investors. 1.1% of Aethlon Medical shares are held by company insiders. Comparatively, 17.9% of Helius Medical Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Helius Medical Technologies had 2 more articles in the media than Aethlon Medical. MarketBeat recorded 2 mentions for Helius Medical Technologies and 0 mentions for Aethlon Medical. Helius Medical Technologies' average media sentiment score of 0.66 beat Aethlon Medical's score of 0.00 indicating that Helius Medical Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
Aethlon Medical Neutral
Helius Medical Technologies Positive

Helius Medical Technologies has lower revenue, but higher earnings than Aethlon Medical. Aethlon Medical is trading at a lower price-to-earnings ratio than Helius Medical Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aethlon Medical$570K11.24-$12.21M-$1.58-0.25
Helius Medical Technologies$434K4.17-$8.85M-$47.53-0.09

Aethlon Medical has a beta of 1.93, indicating that its share price is 93% more volatile than the S&P 500. Comparatively, Helius Medical Technologies has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500.

Aethlon Medical received 201 more outperform votes than Helius Medical Technologies when rated by MarketBeat users. However, 55.56% of users gave Helius Medical Technologies an outperform vote while only 50.11% of users gave Aethlon Medical an outperform vote.

CompanyUnderperformOutperform
Aethlon MedicalOutperform Votes
221
50.11%
Underperform Votes
220
49.89%
Helius Medical TechnologiesOutperform Votes
20
55.56%
Underperform Votes
16
44.44%

Summary

Aethlon Medical beats Helius Medical Technologies on 12 of the 18 factors compared between the two stocks.

Get Helius Medical Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for HSDT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HSDT vs. The Competition

MetricHelius Medical TechnologiesElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$1.81M$3.15B$5.33B$8.39B
Dividend YieldN/A1.72%5.21%4.11%
P/E Ratio-0.7217.0926.7119.71
Price / Sales4.1798.95386.13120.55
Price / CashN/A44.0938.2534.62
Price / Book1.333.736.774.50
Net Income-$8.85M$94.03M$3.23B$248.22M
7 Day Performance6.25%1.75%1.80%0.56%
1 Month Performance1.96%25.13%11.10%13.17%
1 Year Performance-79.39%-11.66%17.11%7.30%

Helius Medical Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HSDT
Helius Medical Technologies
0.7682 of 5 stars
$4.42
+1.6%
N/A-78.8%$1.81M$434,000.00-0.7230Gap Up
AEMD
Aethlon Medical
1.6982 of 5 stars
$0.41
+12.0%
$7.00
+1,607.3%
-8.8%$6.59M$570,000.00-0.2610
LYRA
Lyra Therapeutics
2.0351 of 5 stars
$0.09
-4.1%
$2.00
+2,023.1%
-73.6%$6.24M$1.53M-0.0650
BLAC
Bellevue Life Sciences Acquisition
N/A$1.25
-2.3%
N/A-89.5%$5.05MN/A0.00N/A
CHEK
Check-Cap
0.4148 of 5 stars
$0.82
-0.5%
N/A-60.2%$4.77MN/A-0.2780News Coverage
Analyst Forecast
Gap Up
LUCY
Innovative Eyewear
0.1476 of 5 stars
$1.87
+2.2%
N/A-33.3%$4.59M$1.64M-0.199Positive News
NUWE
Nuwellis
2.5064 of 5 stars
$0.99
+0.1%
$17.00
+1,617.2%
-90.1%$4.33M$8.74M-0.0170Gap Up
AMIX
Autonomix Medical
2.3055 of 5 stars
$1.75
-1.7%
$16.50
+842.9%
-96.0%$4.31MN/A-0.141Gap Up
GCTK
GlucoTrack
0.5759 of 5 stars
$0.15
-4.1%
N/A-99.7%$3.81MN/A0.005Positive News
Gap Up
HSCS
Heart Test Laboratories
2.4005 of 5 stars
$3.47
+1.2%
$13.00
+274.6%
-30.7%$3.75M$14,700.00-0.4410Gap Up
QNRX
Quoin Pharmaceuticals
0.3587 of 5 stars
$6.12
-1.1%
N/A-67.7%$3.60MN/A-1.514

Related Companies and Tools


This page (NASDAQ:HSDT) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners